In vitro activity of rezafungin against bloodstream and intra-abdominal Candida isolates: a large EUCAST-based study.
- DOI
- 10.1016/j.cmi.2026.09.025
- Published
- 2026 Sep 28
- Container
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cmi.2026.09.025,
title = {In vitro activity of rezafungin against bloodstream and intra-abdominal Candida isolates: a large EUCAST-based study.},
author = {Escribano P and Moraga J and Burillo A and Reigadas E and Muñoz P and Guinea J and CANDIMAD study group},
year = {2026},
journal = {Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
doi = {10.1016/j.cmi.2026.09.025},
url = {https://doi.org/10.1016/j.cmi.2026.09.025}
}RIS
TY - JOUR TI - In vitro activity of rezafungin against bloodstream and intra-abdominal Candida isolates: a large EUCAST-based study. AU - Escribano P AU - Moraga J AU - Burillo A AU - Reigadas E AU - Muñoz P AU - Guinea J AU - CANDIMAD study group PY - 2026 JO - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases DO - 10.1016/j.cmi.2026.09.025 UR - https://doi.org/10.1016/j.cmi.2026.09.025 ER -
APA
P, E., J, M., A, B., E, R., P, M., J, G., & group, C. S. (2026). In vitro activity of rezafungin against bloodstream and intra-abdominal Candida isolates: a large EUCAST-based study.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2026.09.025
Source records
- pubmed · retrieved 2026-11-10T12:28:23.334Z